BSE
π₯π₯
1919 ++
16% Up..
π₯π£π₯π£π₯π£π₯π£
Abhi tak Diwali Chal rahi hai ππ
π₯π₯
1919 ++
16% Up..
π₯π£π₯π£π₯π£π₯π£
Abhi tak Diwali Chal rahi hai ππ
Wealthcreatures.com
Deepak Nitrite Low - 2050 Phenol & Acetone prices have started softening Price damage Seems already Done or very close By Would Take Time to cross 2222/2300 All Dips are buying opportunity Street is expecting Muted Q3 but company can suprise us inβ¦
DEEPAK NITRITE
KEEP π
Closed above 2222 good sign
Next resistance - 2300/2341 and above that momentum wld be back in Action
KEEP π
Closed above 2222 good sign
Next resistance - 2300/2341 and above that momentum wld be back in Action
Deepak Nitrite's prospect continues to be driven by phenolics biz
Deepak Nitrite is seeing strong investor confidence with its stock prices more than doubling year to date. The company, which is an established manufacturer of phenol, acetone, and isopropyl alcohol through its subsidiary Deepak Phenolics, has continued to benefit from rising prices of phenol derivatives.
Global supply disruption for these chemicals during the year benefitted the company. Having created Indiaβs largest phenol-acetone plant, the company will continue to accrue benefits from the countryβs growing demand and import substitutions. Being a basic manufacturer, it also has a good edge over cost competition.
While investment rationale remains strong, in the near term there will be challenges too. Prices of phenol seem to be peaking around current levels, while acetone prices have normalized from their peak over the last two months, said analysts at Motilal Oswal Financial Services post Q2 results. EBIT margin in fine and specialty chemicals dipped for the fourth consecutive quarter and the same for basic chemicals normalized, said analysts.
In the ongoing third quarter, prices continue to correct further. Recent chemical and petrochemical prices data by Emkay Global Financial Services indicates that prices of phenol and acetone in November are down 4.9% and 11.4% over October.
Thus, there may not be benefits from rising realisations. Also, the company had achieved its highest-ever plant utilization rate of 120% in 2QFY22, leaving limited growth in this segment for volume accretion, say analysts.
The longer-term prospects nevertheless remain strong and intact. Having fully integrated manufacturing facilities will help it manage and produce chemicals with a competitive advantage. Deepak Phenolics caters to several end-user industries such as agrochemicals, rubber, pharmaceuticals, paper, textile, detergent, colorants, paints, etc. resulting in a natural hedge, say analysts.
Analysts at JM Financial expect βSales, Ebitda and Earnings per share to post 18%, 18%, and 20% CAGR (compound annual growth rate), respectively, over FY21-24E". Despite an aggressive capex of βΉ1,500 crore over FY23-24, they expect its return on capital employed (pre-tax) to remain 32% over FY23E-24E.
Deepak Nitrite is seeing strong investor confidence with its stock prices more than doubling year to date. The company, which is an established manufacturer of phenol, acetone, and isopropyl alcohol through its subsidiary Deepak Phenolics, has continued to benefit from rising prices of phenol derivatives.
Global supply disruption for these chemicals during the year benefitted the company. Having created Indiaβs largest phenol-acetone plant, the company will continue to accrue benefits from the countryβs growing demand and import substitutions. Being a basic manufacturer, it also has a good edge over cost competition.
While investment rationale remains strong, in the near term there will be challenges too. Prices of phenol seem to be peaking around current levels, while acetone prices have normalized from their peak over the last two months, said analysts at Motilal Oswal Financial Services post Q2 results. EBIT margin in fine and specialty chemicals dipped for the fourth consecutive quarter and the same for basic chemicals normalized, said analysts.
In the ongoing third quarter, prices continue to correct further. Recent chemical and petrochemical prices data by Emkay Global Financial Services indicates that prices of phenol and acetone in November are down 4.9% and 11.4% over October.
Thus, there may not be benefits from rising realisations. Also, the company had achieved its highest-ever plant utilization rate of 120% in 2QFY22, leaving limited growth in this segment for volume accretion, say analysts.
The longer-term prospects nevertheless remain strong and intact. Having fully integrated manufacturing facilities will help it manage and produce chemicals with a competitive advantage. Deepak Phenolics caters to several end-user industries such as agrochemicals, rubber, pharmaceuticals, paper, textile, detergent, colorants, paints, etc. resulting in a natural hedge, say analysts.
Analysts at JM Financial expect βSales, Ebitda and Earnings per share to post 18%, 18%, and 20% CAGR (compound annual growth rate), respectively, over FY21-24E". Despite an aggressive capex of βΉ1,500 crore over FY23-24, they expect its return on capital employed (pre-tax) to remain 32% over FY23E-24E.
SEBI approves National Stock Exchange ( NSE) IPO at 2 Lakh Cr valuation
If this is correct then the IPO is valued at FY21 P/E of 56x
NSE did revenues of Rs 5642crs & PAT of 3573crs in FY21
If this is correct then the IPO is valued at FY21 P/E of 56x
NSE did revenues of Rs 5642crs & PAT of 3573crs in FY21
Wealthcreatures.com
KOPRAN 226.85 ALL DIPS are Buying opportunity for those who can wait for 2 - 4 - 6 Qtrs Support@ 220/208
KOPRAN
LOCKED π IN 5% UC
290 π―π
Our conviction To even pick at LC IN FALL.
36 TO 290 β Done TILL NOW
Short Term looking for 305/320/333+
( Those who added near 226 - 230 zone Book Profits π on Upmove if view is short Term)
Longterm - 10x/15Γ/20Γ
LOCKED π IN 5% UC
290 π―π
Our conviction To even pick at LC IN FALL.
36 TO 290 β Done TILL NOW
Short Term looking for 305/320/333+
( Those who added near 226 - 230 zone Book Profits π on Upmove if view is short Term)
Longterm - 10x/15Γ/20Γ
Wealthcreatures.com
CLEAN SCIENCE 2222 π Next Test Levels # 2400/2727++ Longterm # 3300/3900
CLEAN SCIENCE
6% ππ
2454
50% Upmove Done Till Now
6% ππ
2454
50% Upmove Done Till Now
Wealthcreatures.com
TECHNO FUNDA INVESTMENT PICK JINDAL POLY CMP - 825 ACCMULATION ZONE - 760 TO 825 STRONG SUPPORT @ 670 2.5 T0 3 YEARS # 3Γ/4Γ Test levels # 2500/3000++ Only for patience holders S/L - 590 on closing basis or As per Risk
Jindal Poly
11% π£π£
1158
Getting Ready For ATH ππ
Conviction pick
11% π£π£
1158
Getting Ready For ATH ππ
Conviction pick
Wealthcreatures.com
Jindal Poly 11% π£π£ 1158 Getting Ready For ATH ππ Conviction pick
JINDAL POLY
13% π
FRESH ATH
1173
13% π
FRESH ATH
1173
Maximum people Buy Near Resistance instead of NEAR SUPPORT....
&
MAX people Sell Near SUPPORT instead of RESISTANCE .....
&
MAX people Sell Near SUPPORT instead of RESISTANCE .....
https://wealthcreatures.com/2020/06/15/magma-fincorp-dark-horse-for-longterm-can-it-again-cross-its-all-time-high-194/
β
πAlready Multibagger for Us
11x ( 1100% Returns )
18.50 To 211 π― Done Till β Now
Cmp - 205.75
Next Test Levels # 15x/20Γ/25Γ/50Γ ++
Market Cap β Rs. 15762 Cr
No. of Shares β 76.46 Cr
Promotor Holding β 72.52%
FIIβs and DIIβs - 12.92%
Retail Holding β 14.56%
π Recently, in an investor presentation, the company said it was aiming to be among Top
3 NBFCs for consumer and small/medium business finance.
πCompany has financial backing from Adar Poonawalla, CEO of Serum Institute of India - world's largest manufacturer of vaccines.
π Poonawala Fincorp can become bigger player in long run.In terms of stock price returns can give bigger Returns like Bajaj Finance in long term.
β
POONAWALA FINCORP β
(MAGMA FINCORP)πAlready Multibagger for Us
11x ( 1100% Returns )
18.50 To 211 π― Done Till β Now
Cmp - 205.75
Next Test Levels # 15x/20Γ/25Γ/50Γ ++
Market Cap β Rs. 15762 Cr
No. of Shares β 76.46 Cr
Promotor Holding β 72.52%
FIIβs and DIIβs - 12.92%
Retail Holding β 14.56%
π Recently, in an investor presentation, the company said it was aiming to be among Top
3 NBFCs for consumer and small/medium business finance.
πCompany has financial backing from Adar Poonawalla, CEO of Serum Institute of India - world's largest manufacturer of vaccines.
π Poonawala Fincorp can become bigger player in long run.In terms of stock price returns can give bigger Returns like Bajaj Finance in long term.
KOPRAN LTD
Board meeting on 8th Dec'21 to approve issue preferencial Equity shares to promotors Group & others
Board meeting on 8th Dec'21 to approve issue preferencial Equity shares to promotors Group & others
Wealthcreatures.com
BAJAJ HOLDING FResh ATH 5339 Now Getting Ready for 5555/6161/6700/7500++
BAJAJ HOLDING
Fresh ATH
5499 π―π
1460 TO 5499 DONE β TILL NOW
Fresh ATH
5499 π―π
1460 TO 5499 DONE β TILL NOW
Wealthcreatures.com
KOPRAN LOCKED π IN 5% UC 290 π―π Our conviction To even pick at LC IN FALL. 36 TO 290 β Done TILL NOW Short Term looking for 305/320/333+ ( Those who added near 226 - 230 zone Book Profits π on Upmove if view is short Term) Longterm - 10x/15Γ/20Γ
KOPRAN
Fresh ATH
5% π
304.80 π―
36 TO 304.80 done β Till now
Fresh ATH
5% π
304.80 π―
36 TO 304.80 done β Till now